- Previous Close
65.75 - Open
65.12 - Bid 61.88 x --
- Ask 63.06 x --
- Day's Range
59.98 - 66.08 - 52 Week Range
59.98 - 116.60 - Volume
26,248 - Avg. Volume
33,867 - Market Cap (intraday)
4.105B - Beta (5Y Monthly) 1.33
- PE Ratio (TTM)
4.21 - EPS (TTM)
14.87 - Earnings Date Apr 30, 2025
- Forward Dividend & Yield 12.00 (10.51%)
- Ex-Dividend Date May 18, 2023
- 1y Target Est
--
Wacker Chemie AG, together with its subsidiaries, provides chemical products worldwide. It operates through four divisions: Wacker Silicones, Wacker Polymers, Wacker Biosolutions, and Wacker Polysilicon. The Wacker Silicones division offers silanes, siloxanes, silicone fluids, silicone emulsions, silicone elastomers, silicone resins, and pyrogenic silicas. The Wacker Polymers division provides binders and polymeric additives, such as dispersible polymer powder and vinyl acetate-ethylene dispersions, which are used in construction, paper, adhesive, paint, coating, and basic chemical industries. The Wacker Biosolutions division offers customized biotech and catalog products for fine chemicals, such as pharmaceutical proteins, vaccines, cyclodextrins, cysteine, polyvinyl acetate solid resins, and acetylacetone for pharmaceutical actives, food additives, and agrochemicals. The Wacker Polysilicon division produces hyperpure polysilicon for use in semiconductor and solar sectors. Wacker Chemie AG was founded in 1914 and is headquartered in Munich, Germany. The company operates as a subsidiary of Dr. Alexander Wacker Familiengesellschaft mbH.
www.wacker.com16,358
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 0NR4.IL
View MorePerformance Overview: 0NR4.IL
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is DAX P (^GDAXI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 0NR4.IL
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 0NR4.IL
View MoreValuation Measures
Market Cap
3.27B
Enterprise Value
3.98B
Trailing P/E
13.56
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.57
Price/Book (mrq)
0.70
Enterprise Value/Revenue
0.70
Enterprise Value/EBITDA
4.93
Financial Highlights
Profitability and Income Statement
Profit Margin
9.91%
Return on Assets (ttm)
5.16%
Return on Equity (ttm)
16.39%
Revenue (ttm)
7.46B
Net Income Avi to Common (ttm)
739M
Diluted EPS (ttm)
14.87
Balance Sheet and Cash Flow
Total Cash (mrq)
1.14B
Total Debt/Equity (mrq)
33.08%
Levered Free Cash Flow (ttm)
290.95M